The Pharma Data

DECEMBER 23, 2020

” Dr. Stanley Plotkin , Professor Emeritus at The Wistar Institute, said, “INOVIO’s DNA vaccine appeared to be quite safe with few significant reactions but yet induced both antibody and T cell responses to SARS-CoV-2.” . PLYMOUTH MEETING, Pa. , PLYMOUTH MEETING, Pa. , mg and 2.0

DNA 40

DNA Vaccine Vaccination Immune Response 40

Worldwide Clinical Trials

JULY 8, 2024

Genetic Factors : Certain genetic mutations, such as those in DNA repair genes, can affect how cells respond to radiation. Individuals with familial cancer syndrome may have inherited mutations that predispose them to cancer development, affecting genes involved in DNA repair and cell cycle regulation.

Hormones 130

Hormones Regulation Clinical Trials Clinical Trials 130

Intouch Solutions

SEPTEMBER 27, 2024

Manufacturers of drugs and diagnostics have to create a plan for their products/therapies to become part of an algorithm and to have AI adopters on staff or as consultants as the space continues to broaden. ctDNA: New data was presented demonstrating major advances in the understanding of circulating tumor DNA (ctDNA).

DNA 59

DNA Trials Antibody Marketing 59

XTalks

JANUARY 19, 2024

Regulatory bodies have demonstrated preparedness for the surge in radiopharmaceuticals as evidenced by inaugural Chemistry, Manufacturing and Controls (CMC) Development and Readiness Pilot (CDRP) programs to expedite commercial manufacturing, US Food and Drug Administration (FDA) approvals and marketing authorizations.

DNA 66

DNA Radiology FDA Approval Development 66

XTalks

MARCH 10, 2021

The T cell test from Adaptive Biotechnologies detects DNA sequences from T cells, specifically sequencing T cell receptors (TCR) on CD8+ T cells. Cue Health is planning to manufacture more than 100,000 tests per day by the summer. 3. Quidel QuickVue At-Home COVID-19 Antigen Test.

Protein 98

Protein RNA Antibody Production 98

XTalks

SEPTEMBER 14, 2020

In April alone, food and accommodation services had dropped by a good 42 percent, manufacturing followed with a 22.5 Meanwhile, researchers at the University of Toronto are developing synthetic therapeutic antibodies that they say are more potent than naturally occurring antibodies and which can be readily manufactured in large quantities.

Vaccine 92

Vaccine Vaccination Antibody Life Science 92